Published in Clin Radiol on September 01, 1992
Sellar and parasellar metastatic tumors. Int J Surg Oncol (2011) 0.80
Pituitary Metastasis from Renal Cell Carcinoma: Description of a Case Report. Am J Case Rep (2017) 0.77
Diagnosis and management of isolated pituitary metastasis from adenocarcinoma of unknown origin presenting as loss of libido. BMJ Case Rep (2015) 0.75
Breast cancer metastasis to pituitary infandibulum. Iran J Med Sci (2011) 0.75
Metastatic prostate adenocarcinoma presenting central diabetes insipidus. Case Rep Med (2012) 0.75
Pituitary metastasis of rhabdomyosarcoma: a case report and review of the literature. J Med Case Rep (2014) 0.75
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol (2001) 5.25
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. Clin Cancer Res (1999) 3.24
Opposing motor activities are required for the organization of the mammalian mitotic spindle pole. J Cell Biol (1996) 3.15
Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain (2000) 2.96
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol (2002) 2.87
Socio-economic deprivation and stage of disease at presentation in women with breast cancer. Ann Oncol (2000) 2.45
Molecular requirements for bi-directional movement of phagosomes along microtubules. J Cell Biol (1997) 2.13
Heart failure in outpatients: a randomized trial of digoxin versus placebo. N Engl J Med (1982) 2.09
Analysis of dynactin subcomplexes reveals a novel actin-related protein associated with the arp1 minifilament pointed end. J Cell Biol (1999) 2.06
Magnetic resonance imaging findings within 5 days of status epilepticus in childhood. Brain (2002) 1.98
Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study. J Clin Oncol (2000) 1.77
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days. Br J Cancer (2006) 1.66
Studies on the Hemorrhagic Agent 3,3'-Methylenebis (4-Hydroxycoumarin): IV. The Pathologic Findings after the Administration of Dicumarol. Am J Pathol (1944) 1.63
Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C. J Clin Oncol (2001) 1.62
Voxel similarity measures for 3-D serial MR brain image registration. IEEE Trans Med Imaging (2000) 1.61
Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer. J Clin Oncol (1998) 1.61
Tentorial dural arteriovenous fistulae: endovascular treatment with transvenous coil embolisation. Neuroradiology (1999) 1.55
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Ann Oncol (2003) 1.48
Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. Eur J Cancer (2004) 1.44
Case of the month: congenital unilateral proptosis. Br J Radiol (2002) 1.41
The role of CT and MR in imaging the complications of sickle cell disease. Clin Radiol (1997) 1.40
Identification and characterization of a conserved erythroid-specific enhancer located in intron 8 of the human 5-aminolevulinate synthase 2 gene. J Biol Chem (1998) 1.29
Actin-related protein 1 and cytoplasmic dynein-based motility - what's the connection? Trends Cell Biol (1996) 1.26
Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation. Arch Dis Child (1990) 1.22
Registration of MR and CT images for skull base surgery using point-like anatomical features. Br J Radiol (1991) 1.22
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial. Br J Cancer (2006) 1.22
Imaging and pathological features of primary malignant rhabdoid tumours of the brain and spine. Neuroradiology (1997) 1.21
Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients. Clin Cancer Res (1998) 1.21
Molecular regulation of heme biosynthesis in higher vertebrates. Prog Nucleic Acid Res Mol Biol (1995) 1.20
Scintigraphic evaluation of left ventricular aneurysm. Am J Cardiol (1980) 1.19
The ontology of craniofacial development and malformation for translational craniofacial research. Am J Med Genet C Semin Med Genet (2013) 1.19
Heterotopic pancreas as lead point in intussusception: new variant of vitellointestinal tract malformation. Pediatr Dev Pathol (1999) 1.19
Molecular regulation of 5-aminolevulinate synthase. Diseases related to heme biosynthesis. Mol Biol Med (1990) 1.18
Transcriptional regulation of the human erythroid 5-aminolevulinate synthase gene. Identification of promoter elements and role of regulatory proteins. J Biol Chem (1997) 1.14
Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. J Bone Joint Surg Br (1998) 1.12
Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia. J Bioenerg Biomembr (1995) 1.11
Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: a meta-analysis of individual data from 6171 patients. Ann Oncol (2011) 1.11
Evidence of vascular disease from CT scanning in late onset epilepsy. J Neurol Neurosurg Psychiatry (1984) 1.08
Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial. J Clin Oncol (2002) 1.07
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours. Br J Cancer (2000) 1.07
Posterior circulation stroke in childhood: risk factors and recurrence. Neurology (2002) 1.07
Answering patients' needs: oral alternatives to intravenous therapy. Oncologist (2001) 1.06
Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies. Ann Neurol (2001) 1.06
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin. Br J Cancer (2012) 1.06
Spectrum of global left ventricular responses to supine exercise. Limitation in the use of ejection fraction in identifying patients with coronary artery disease. Am J Cardiol (1983) 1.04
Hormonal control of apical membrane Na transport in epithelia. Studies with fluctuation analysis. J Gen Physiol (1983) 1.04
Gene structure and expression study of the SEDL gene for spondyloepiphyseal dysplasia tarda. Genomics (2000) 1.03
Accurate frameless registration of MR and CT images of the head: applications in planning surgery and radiation therapy. Radiology (1994) 1.02
Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group. Ann Oncol (2004) 1.01
Hippocampal involvement in spatial and working memory: a structural MRI analysis of patients with unilateral mesial temporal lobe sclerosis. Brain Cogn (1999) 1.01
Sources of error in comparing functional magnetic resonance imaging and invasive electrophysiological recordings. J Neurosurg (2000) 1.00
Measurement of blood flow, oxygen utilisation, oxygen extraction ratio, and fractional blood volume in human brain tumours and surrounding oedematous tissue. Br J Radiol (1985) 1.00
X-linked sideroblastic anemia and ataxia: linkage to phosphoglycerate kinase at Xq13. Am J Hum Genet (1991) 1.00
Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients. Cancer Chemother Pharmacol (1999) 0.99
Stereo augmented reality in the surgical microscope. Stud Health Technol Inform (1999) 0.99
Genotype and clinical care correlations in craniosynostosis: findings from a cohort of 630 Australian and New Zealand patients. Am J Med Genet C Semin Med Genet (2013) 0.98
Human erythroid 5-aminolevulinate synthase. Gene structure and species-specific differences in alternative RNA splicing. J Biol Chem (1992) 0.97
Cyclosporine-related reversible posterior leukoencephalopathy: MRI. Neuroradiology (1997) 0.97
Use of positron emission tomography in pharmacokinetic studies to investigate therapeutic advantage in a phase I study of 120-hour intravenous infusion XR5000. J Clin Oncol (2003) 0.96
Rasmussen's encephalitis: neuroimaging findings in 21 patients with a closer look at the basal ganglia. Pediatr Neurosurg (1998) 0.96
Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage? Ann Oncol (2006) 0.95
A landmark-free framework for the detection and description of shape differences in embryos. Conf Proc IEEE Eng Med Biol Soc (2011) 0.93
Effects of ouabain and furosemide on basolateral membrane Na efflux of frog skin. Am J Physiol (1983) 0.92
Chromosome instability and benefit from adjuvant anthracyclines in breast cancer. Br J Cancer (2012) 0.92
Dural sinus thrombosis. Diagnosis and follow-up by magnetic resonance angiography and imaging. Neuroradiology (1991) 0.91
Action of polyvalent cations on sodium transport across skin of larval and adult Rana catesbeiana. J Exp Zool (1985) 0.91
A new tool for quantifying and characterizing asymmetry in bilaterally paired structures. Conf Proc IEEE Eng Med Biol Soc (2013) 0.91
Intrasphenoid cephalocele: MRI in two cases. Neuroradiology (1999) 0.90
A comparison of CT and MRI in the assessment of the pituitary and parasellar region. Clin Radiol (1991) 0.90
Na+ and K+ transport at basolateral membranes of epithelial cells. II. K+ efflux and stoichiometry of the Na,K-ATPase. J Gen Physiol (1986) 0.89
The urological care and outcome of pregnancy after urinary tract reconstruction. BJU Int (2004) 0.89
Influence of coronary artery disease on pulmonary uptake of thallium-201. Am J Cardiol (1980) 0.88
A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer. Ann Oncol (2003) 0.88
The use of prophylactic antibiotics in ultrasound-guided transrectal prostate biopsy. Clin Radiol (1997) 0.88
Thalamic changes with mesial temporal sclerosis: MRI. Neuroradiology (2000) 0.88
Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours? Eur J Endocrinol (2002) 0.87
Early changes in left ventricular size and function after correction of left ventricular volume overload. Am J Cardiol (1981) 0.87
FXY2/MID2, a gene related to the X-linked Opitz syndrome gene FXY/MID1, maps to Xq22 and encodes a FNIII domain-containing protein that associates with microtubules. Genomics (1999) 0.87
Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae. J Neurol Neurosurg Psychiatry (2002) 0.87
A dynamic model of hand-and-foot syndrome in patients receiving capecitabine. Clin Pharmacol Ther (2008) 0.87
Electrical and transport characteristics of skin of larval Rana catesbeiana. Am J Physiol (1979) 0.87
Phase I and pharmacokinetic (PK) study of MAG-CPT (PNU 166148): a polymeric derivative of camptothecin (CPT). Br J Cancer (2004) 0.85
Perfusion magnetic resonance abnormalities in patients with sickle cell disease. Ann Neurol (2001) 0.85
Multidisciplinary management of Opitz G BBB syndrome. Ann Plast Surg (2005) 0.85
Erlotinib in combination with pemetrexed for patients with advanced non-small-cell lung cancer (NSCLC): a phase I dose-finding study. Ann Oncol (2010) 0.85
Of linens and laces--the eighth anniversary of the gated blood pool scan. Semin Nucl Med (1979) 0.85
Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancer. Br J Cancer (2003) 0.85
An evaluation of the use of 99Tcm-dimercaptosuccinic acid (DMSA) as a static renal imaging agent. Br J Radiol (1978) 0.85
Cloning and characterization of a functional P2X receptor from larval bullfrog skin. Am J Physiol Cell Physiol (2001) 0.84
The identification of cerebral volume changes in treated growth hormone-deficient adults using serial 3D MR image processing. J Comput Assist Tomogr (2000) 0.83
The rational development of capecitabine from the laboratory to the clinic. Anticancer Res (2003) 0.83
The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patients. Cancer Res (1999) 0.83
An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer. Eur J Cancer (2008) 0.82
Na+ and K+ transport at basolateral membranes of epithelial cells. I. Stoichiometry of the Na,K-ATPase. J Gen Physiol (1986) 0.82